Prime Medicine, Correlations

PRME Etf  USD 2.65  0.25  8.62%   
The current 90-days correlation between Prime Medicine, Common and Sana Biotechnology is 0.07 (i.e., Significant diversification). The correlation of Prime Medicine, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Prime Medicine, Correlation With Market

Average diversification

The correlation between Prime Medicine, Common and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prime Medicine, Common. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with Prime Etf

  0.68VANI Vivani MedicalPairCorr
  0.66VTYX Ventyx BiosciencesPairCorr

Moving against Prime Etf

  0.31VALN Valneva SE ADRPairCorr
  0.46VRNA Verona Pharma PLCPairCorr
  0.4KTTAW Pasithea TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CRSPEDIT
NTLACRBU
RPRXSANA
OCEANTLA
CRSPNTLA
RPRXDNA
  
High negative correlations   
RPRXOCEA
OCEADNA
RPRXNTLA
DNACRBU
RPRXCRBU
SANANTLA

Prime Medicine, Constituents Risk-Adjusted Indicators

There is a big difference between Prime Etf performing well and Prime Medicine, ETF doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prime Medicine,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BEAM  3.40  0.24  0.06  0.24  3.78 
 8.04 
 21.42 
CRBU  3.00 (0.63) 0.00 (1.55) 0.00 
 8.22 
 17.35 
NTLA  3.57 (0.51) 0.00 (0.41) 0.00 
 9.25 
 22.98 
SANA  8.22  1.24  0.17  0.47  6.58 
 15.22 
 176.41 
RPHM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DNA  6.45  0.45  0.07  0.27  6.44 
 14.49 
 36.96 
OCEA  6.98 (2.68) 0.00 (19.13) 0.00 
 15.38 
 51.00 
RPRX  1.11  0.40  0.38 (0.69) 0.66 
 2.38 
 14.04 
EDIT  6.37  0.24  0.03  0.11  8.46 
 12.04 
 119.53 
CRSP  2.87 (0.02) 0.00 (0.04) 0.00 
 6.48 
 19.32